Listen Online - Listen on Mobile Radio.com | Mobile App Info

Nevada Lawmakers Seek Business Data on Costly Prescriptions

CARSON CITY, Nev. (AP) — Nevada lawmakers are doubling down on a push for information on why drugmakers are dramatically increasing prescription drug prices.

A bill heard Monday would require pharmaceutical companies that produce particularly expensive drugs to publicly report their profits, sticker prices, discounts for bulk buyers, and costs of research and manufacturing.

The state would consult drugmakers to redact data considered trade secrets.

Pharmaceutical representatives say the information targeted is not representative of drugs’ values or the insurance industry’s role in driving up prices.

Market experts say that transparency alone will not lead to patients paying less for their prescriptions.

Monday’s Assembly Bill 215 does not include price caps or other cost-cutting mechanisms.

A proposal heard last week, Senate Bill 265 seeks similar reports as well as reimbursements specifically regarding insulin, among other things.

Comments

Leave a Reply

Please log in using one of these methods to post your comment:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From CBS Las Vegas

Introducing Your New Podcast Network Play.it
New CBS Local Sports

Listen Live